Background & Aims Although non-alcoholic fatty liver disease (NAFLD), non-alcoholic
steatohepatitis (NASH) and NASH with advanced fibrosis are closely associated with type 2
diabetes mellitus (T2DM), their global prevalence rates have not been well described. Our
aim was to estimate the prevalence of NAFLD, NASH, and advanced fibrosis among patients
with T2DM, by regions of the world. Methods We searched for terms including NAFLD,
NASH and T2DM in studies published from January 1989 to September 2018, using …